The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,612
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Correa, P. (1992) · PubMed · Cited by 3,216
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Cited by
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Suerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,987
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
“As such, the risk is increased in subjects colonized with cagA-positive strains (337, 489), but also in those with a genetic predisposition to higher IL-1 production in response to colonization (157).”
BackgroundInfluentialNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Self-citationCancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Malfertheiner, P., Chan, F. K., & McColl, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,488
Self-citationHelicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-10 · Cited by 1,442
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Risk factors for periodontal disease
Genco, R. J., & Borgnakke, W. S. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00457.x · Cited by 1,232
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Lanas, A., & Chan, F. K. L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32404-7 · Cited by 984
Helicobacter pylori persistence: biology and disease
Blaser, M. J., & Atherton, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420925 · Cited by 948
El-Omar, E. M., Rabkin, C. S., Gammon, M. D., Vaughan, T. L., Risch, H. A., Schoenberg, J. B., Stanford, J. L., Mayne, S. T., Goedert, J., Blot, W. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00157-4 · Cited by 917
Self-citationHartgrink, H. H., Jansen, E. P., van Grieken, N. C., & van de Velde, C. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60617-6 · Cited by 875
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
Inflammation, atrophy, and gastric cancer
Fox, J. G., & Wang, T. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30111 · Cited by 772
The balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Helicobacter pylori in Health and Disease
Cover, T. L., & Blaser, M. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.073 · Cited by 713
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori
Salama, N. R., Hartung, M. L., & Müller, A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3016 · Cited by 663
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Host-Bacterial Interactions in Helicobacter pylori Infection
Amieva, M. R., & El–Omar, E. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.009 · Cited by 632
Self-citationFigueiredo, C. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.22.1680 · Cited by 625
Chemical basis of inflammation-induced carcinogenesis
Ohshima, H., Tatemichi, M., & Sawa, T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00283-2 · Cited by 620
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Persistent bacterial infections: the interface of the pathogen and the host immune system
Monack, D. M., Mueller, A., & Falkow, S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro955 · Cited by 572
THE PATHOGENESIS OF HELICOBACTER PYLORI–INDUCED GASTRO-DUODENAL DISEASES
Atherton, J. C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100125 · Cited by 567
Ernst, P. B., & Gold, B. D. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.615 · Cited by 554
Helicobacter infection and gastric neoplasia
Peek, R. M., & Crabtree, J. E. (2006) · The Journal of Pathology · doi:10.1002/path.1868 · Cited by 550
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
Atherton, J. C., & Blaser, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38605 · Cited by 549
Fischer, W., Püls, J., Buhrdorf, R., Gebert, B., Odenbreit, S., & Haas, R. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02714.x · Cited by 508
Murphy, G., Pfeiffer, R., Camargo, M. C., & Rabkin, C. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.001 · Cited by 500
Self-citationGenetics and Molecular Pathogenesis of Gastric Adenocarcinoma
Tan, P., & Yeoh, K.-G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.059 · Cited by 492
Machado, J. C., Figueiredo, C., Canedo, P., Pharoah, P., Carvalho, R., Nabais, S., Castro Alves, C., Campos, M. L., Van Doorn, L.-J., Caldas, C., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00899-0 · Cited by 483
Activation of β-catenin by carcinogenic Helicobacter pylori
Franco, A. T., Israel, D. A., Washington, M. K., Krishna, U., Fox, J. G., Rogers, A. B., Neish, A. S., Collier-Hyams, L., Perez-Perez, G. I., Hatakeyama, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504927102 · Cited by 479
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Chow, J., Tang, H., & Mazmanian, S. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.010 · Cited by 448
Ponder, B. A. J. (2001) · Nature · doi:10.1038/35077207 · Cited by 446
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Bent, R., Moll, L., Grabbe, S., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082155 · Cited by 444
Natural history and epidemiology of Helicobacter pylori infection
Go, M. F. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.0160s1003.x · Cited by 440
Leung, W. K. (2004) · Gut · doi:10.1136/gut.2003.034629 · Cited by 437
Machado, J. C., Pharoah, P., Sousa, S., Carvalho, R., Oliveira, C., Figueiredo, C., Amorim, A., Seruca, R., Caldas, C., Carneiro, F., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28000 · Cited by 426
Review article: the epidemiology and prevention of gastric cancer
Fock, K. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12814 · Cited by 424
A multifaceted role for polyamines in bacterial pathogens
Shah, P., & Swiatlo, E. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06126.x · Cited by 424
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Niwa, T., Tsukamoto, T., Toyoda, T., Mori, A., Tanaka, H., Maekita, T., Ichinose, M., Tatematsu, M., & Ushijima, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2755 · Cited by 417
2011: the immune hallmarks of cancer
Cavallo, F., De Giovanni, C., Nanni, P., Forni, G., & Lollini, P.-L. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0968-0 · Cited by 415
Single nucleotide polymorphisms and the future of genetic epidemiology
Schork, N. J., Fallin, D., & Lanchbury, J. S. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580402.x · Cited by 412
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410
Family History of Gastric Cancer and Helicobacter pylori Treatment
Choi, I. J., Kim, C. G., Lee, J. Y., Kim, Y.-I., Kook, M.-C., Park, B., & Joo, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1909666 · Cited by 407
McLean, M. H., & El-Omar, E. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.143 · Cited by 395
Self-citationImmunology and Evolution of Infectious Disease
Frank, S. A. (2002) · Princeton University Press eBooks · doi:10.1515/9780691220161 · Cited by 393
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
Cytokine and cytokine receptor gene polymorphisms and their functionality
Smith, A. J. P., & Humphries, S. E. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.006 · Cited by 374
Chiba, T., Marusawa, H., & Ushijima, T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.009 · Cited by 381
Clinical epidemiology of gastric cancer
Ang, T., & Fock, K. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014174 · Cited by 380
Pathogenesis of Helicobacter pylori infection
Peek, R. M. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-005-0204-8 · Cited by 377
IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy
Mantovani, A., Barajon, I., & Garlanda, C. (2018) · Immunological Reviews · doi:10.1111/imr.12614 · Cited by 376
Helicobacter pylori genetic diversity and risk of human disease
Blaser, M. J., & Berg, D. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12672 · Cited by 376
Hwang, I.-R., Kodama, T., Kikuchi, S., Sakai, K., Peterson, L. E., Graham, D. Y., & Yamaoka, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37043 · Cited by 376
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373
Casanova, J.-L., Abel, L., & Quintana-Murci, L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101335 · Cited by 366
Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S. N., Jeyes, J., Schinas, J., Bacani, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018275 · Cited by 361
Asia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
Yamaoka, Y., Kikuchi, S., El–Zimaity, H. M. T., Gutierrez, O., Osato, M. S., & Graham, D. Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.34781 · Cited by 351
Macarthur, M., Hold, G. L., & El-Omar, E. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00475.2003 · Cited by 348
Self-citationFuruta, T., El–Omar, E. M., Xiao, F., Shirai, N., Takashima, M., & Sugimurra, H. (2002) · Gastroenterology · doi:10.1053/gast.2002.34156 · Cited by 346
Self-citationRébé, C., & Ghiringhelli, F. (2020) · Cancers · doi:10.3390/cancers12071791 · Cited by 337
Israel, D. A., Salama, N., Arnold, C. N., Moss, S. F., Ando, T., Wirth, H.-P., Tham, K. T., Camorlinga, M., Blaser, M. J., Falkow, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11450 · Cited by 336
Kamangar, F., Dawsey, S. M., Blaser, M. J., Perez-Perez, G. I., Pietinen, P., Newschaffer, C. J., Abnet, C. C., Albanes, D., Virtamo, J., & Taylor, P. R. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj393 · Cited by 330
Toller, I. M., Neelsen, K. J., Steger, M., Hartung, M. L., Hottiger, M. O., Stucki, M., Kalali, B., Gerhard, M., Sartori, A. A., Lopes, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100959108 · Cited by 330
Helicobacter pylori and extragastric diseases: A review
Gravina, A. G., Zagari, R. M., Musis, C. D., Romano, L., Loguercio, C., & Romano, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i29.3204 · Cited by 328
Cancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
Self-citationEpidemiology of upper gastrointestinal malignancies
CREW, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.021 · Cited by 323
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Jankowski, J. A., Harrison, R. F., Perry, I., Balkwill, F., & Tselepis, C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03411-5 · Cited by 316
Genetic susceptibility and gastric cancer risk
González, C. A., Sala, N., & Capellá, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10466 · Cited by 316
The importance of interleukin 1β in Helicobacter pylori associated disease
EL-OMAR, E. M. (2001) · Gut · doi:10.1136/gut.48.6.743 · Cited by 315
Self-citationChen, H., Wilkins, L. M., Aziz, N., Cannings, C., Wyllie, D. H., Bingle, C., Rogus, J., Beck, J. D., Offenbacher, S., Cork, M. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi469 · Cited by 310
Control of gut differentiation and intestinal-type gastric carcinogenesis
Yuasa, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1141 · Cited by 307
Epidemiology of Helicobacter pylori infection and gastric cancer in Asia
Fock, K. M., & Ang, T. L. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06188.x · Cited by 304
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
Takeshima, H., & Ushijima, T. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0079-0 · Cited by 300
Takahashi-Kanemitsu, A., Knight, C. T., & Hatakeyama, M. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0339-5 · Cited by 299
Active immunization against cancer with dendritic cells: The near future
Steinman, R. M., & Dhodapkar, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1503 · Cited by 299
Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses
Liu, P. T., Schenk, M., Walker, V. P., Dempsey, P. W., Kanchanapoomi, M., Wheelwright, M., Vazirnia, A., Zhang, X., Steinmeyer, A., Zügel, U., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005810 · Cited by 299
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
Mechanisms of Disease: inflammation and the origins of cancer
Moss, S. F., & Blaser, M. J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0081 · Cited by 291
Inflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
Metadata
- Authors
- El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F., & Rabkin, C. S.
- Venue
- Nature
- Published
- 2000-03-23
- Volume
- 404
- Issue
- 6776
- Pages
- 398-402
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992945893
- Cited by
- 2,366
- References
- 47
- FWCI
- 143.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.